Literature DB >> 6176583

Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies.

D E Smith, L T Furcht.   

Abstract

Monoclonal antibodies to human plasma fibronectin were used to study the topological arrangement of several biologically active sites on the 220,000-dalton fibronectin subunit. Plasma fibronectin was cleaved into a number of biologically active fragments by trypsin and cathepsin D. Fragments that bind gelatin and heparin bind to both gelatin and heparin were isolated by affinity chromatography. These fragments were further characterized by their ability to bind to two different monoclonal antibodies: monoclonal 2-8 and monoclonal 180-8. Using this approach, we have established the positions of two unique heparin-, a gelatin-, and two monoclonal antibody-binding sites on the fibronectin subunit.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors.

Authors:  J K Czop; J L Kadish; D M Zepf; K F Austen
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

3.  The effects of various nutritional supplements on the growth, migration and differentiation of Xenopus laevis neural crest cells in vitro.

Authors:  H C Wilson; N C Milos
Journal:  In Vitro Cell Dev Biol       Date:  1987-05

4.  Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity.

Authors:  A Garcia-Pardo; A Rostagno; B Frangione
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

5.  Monoclonal antibody against the N-terminal end of human plasma fibronectin.

Authors:  T Vartio; E M Salonen; G De Petro; S Barlati; V Miggiano; C Stähli; G Virgallita; B Takács; A Vaheri
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

6.  Collagen-fibronectin interactions in normal and Rous sarcoma virus-transformed avian tendon cells: possible mechanisms for increased extracellular matrix turnover after transformation.

Authors:  L M Chan; C Hatier; G Parry; Z Werb; M J Bissell
Journal:  In Vitro Cell Dev Biol       Date:  1987-04

Review 7.  The role of cell adhesion proteins--laminin and fibronectin--in the movement of malignant and metastatic cells.

Authors:  J B McCarthy; M L Basara; S L Palm; D F Sas; L T Furcht
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria.

Authors:  G M Vercellotti; J B McCarthy; P Lindholm; P K Peterson; H S Jacob; L T Furcht
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

9.  Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro.

Authors:  J B McCarthy; L T Furcht
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Laminin binds specifically to sulfated glycolipids.

Authors:  D D Roberts; C N Rao; J L Magnani; S L Spitalnik; L A Liotta; V Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.